Pfizer’s COVID-19 vaccine heads into approval phase

Pfizer is preparing to formally ask for emergency use authorization for its vaccine in the U.S., after new data showed it's safe and 95 per cent effective. The vaccine’s approval in Canada could come within the next couple of months.